Your browser doesn't support javascript.
loading
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Parker, Christopher C; Clarke, Noel W; Cook, Adrian D; Kynaston, Howard G; Petersen, Peter Meidahl; Catton, Charles; Cross, William; Logue, John; Parulekar, Wendy; Payne, Heather; Persad, Rajendra; Pickering, Holly; Saad, Fred; Anderson, Juliette; Bahl, Amit; Bottomley, David; Brasso, Klaus; Chahal, Rohit; Cooke, Peter W; Eddy, Ben; Gibbs, Stephanie; Goh, Chee; Gujral, Sandeep; Heath, Catherine; Henderson, Alastair; Jaganathan, Ramasamy; Jakobsen, Henrik; James, Nicholas D; Kanaga Sundaram, Subramanian; Lees, Kathryn; Lester, Jason; Lindberg, Henriette; Money-Kyrle, Julian; Morris, Stephen; O'Sullivan, Joe; Ostler, Peter; Owen, Lisa; Patel, Prashant; Pope, Alvan; Popert, Richard; Raman, Rakesh; Røder, Martin Andreas; Sayers, Ian; Simms, Matthew; Wilson, Jim; Zarkar, Anjali; Parmar, Mahesh K B; Sydes, Matthew R.
Afiliación
  • Parker CC; Department of Oncology, Royal Marsden NHS Foundation Trust, Sutton, UK; Institute of Cancer Research, Sutton, UK.
  • Clarke NW; Department of Oncology, Genito-Urinary Cancer Research Group, The Christie Hospital, Manchester, UK; Department of Surgery, The Christie Hospital, Manchester, UK; Department of Urology, Salford Royal Hospitals, Manchester, UK.
  • Cook AD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
  • Kynaston HG; Department of Urology, Cardiff University School of Medicine, Cardiff University, Cardiff, UK.
  • Petersen PM; Department of Oncology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Catton C; Department of Radiation Oncology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada.
  • Cross W; Department Of Urology, St James's University Hospital, Leeds, UK.
  • Logue J; Department of Oncology, The Christie Hospital, Manchester, UK.
  • Parulekar W; Department of Oncology, Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Payne H; Department of Oncology, University College London Hospitals, London, UK.
  • Persad R; Department of Urology, Bristol Urological Institute, North Bristol Hospitals, Bristol, UK.
  • Pickering H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
  • Saad F; Department of Urology, Centre Hospitalier de l'Université de Montreal, Montreal, QC, Canada.
  • Anderson J; Department of Oncology, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
  • Bahl A; Department of Oncology, Bristol Cancer Institute, University Hospitals Bristol, Bristol, UK.
  • Bottomley D; St James's Institute of Oncology, Leeds, UK.
  • Brasso K; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Chahal R; Department of Urology, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
  • Cooke PW; Department of Urology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Eddy B; Department of Urology, East Kent Hospitals University Foundation Trust, Canterbury, UK.
  • Gibbs S; Department of Oncology, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK.
  • Goh C; Department of Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
  • Gujral S; Department of Urology, Barking, Havering and Redbridge University Hospitals NHS Trust, Romford, UK.
  • Heath C; Department of Clinical Oncology, University Hospital Southampton, Southampton, UK.
  • Henderson A; Department of Urology, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.
  • Jaganathan R; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Jakobsen H; Department of Urology, Herlev University Hospital, Herlev, Denmark.
  • James ND; Institute of Cancer Research, London, UK; Department of Oncology, Royal Marsden NHS Foundation Trust, London, UK.
  • Kanaga Sundaram S; Department of Urology, Mid Yorkshire Hospitals NHS Trust, Wakefield, UK.
  • Lees K; Kent Oncology Centre, Maidstone Hospital, Kent, UK.
  • Lester J; Department of Oncology, South West Wales Cancer Centre, Swansea, UK.
  • Lindberg H; Department of Oncology, Herlev University Hospital, Herlev, Denmark.
  • Money-Kyrle J; Department of Oncology, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK.
  • Morris S; Department of Clinical Oncology, Guys Hospital, London, UK.
  • O'Sullivan J; Department of Clinical Oncology, Belfast Health and Social Care Trust, Belfast, UK.
  • Ostler P; Mount Vernon Cancer Centre, Northwood, UK.
  • Owen L; Department of Oncology, Leeds Cancer Centre, St James's University Hospital, Leeds, UK.
  • Patel P; Department of Urology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Pope A; Department of Urology, Hillingdon Hospital, Middlesex, UK; Mount Vernon Hospital, Northwood, UK; Mount Vernon Cancer Centre, Northwood, UK.
  • Popert R; Department of Urology, Guys Hospital, London, UK.
  • Raman R; Department of Clinical Oncology, Kent Oncology Centre, Canterbury, UK.
  • Røder MA; Department of Urology, Copenhagen Prostate Cancer Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Sayers I; Department of Oncology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Simms M; Department of Urology, Hull University Hospitals NHS Trust, Hull, UK.
  • Wilson J; Department of Urology, Anuerin Bevan University Health Board, Newport, UK.
  • Zarkar A; Department of Oncology, University Hospital Birmingham, Birmingham, UK.
  • Parmar MKB; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK.
  • Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL, London, UK. Electronic address: m.sydes@ucl.ac.uk.
Lancet ; 396(10260): 1413-1421, 2020 10 31.
Article en En | MEDLINE | ID: mdl-33002429
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Adenocarcinoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Prostatectomía / Neoplasias de la Próstata / Adenocarcinoma Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido